Skip to main content
World Congress on Medical Oncology
Olympic Paris 2024
Test 4
Test 1
Test 2
Test 5
Test 3
Test clone mv
Olympic Paris 2024
Olympic Paris 2024 - VIP - Boss Ticket
Olympic Paris 2024
Finance Code Test
Concrete Institute of Australia’s Biennial National Conference 2025
Concrete Institute of Australia’s Biennial National Conference 2025
Test Goldenowl Conference
Virtual Event 01
Paris Olypmpic Clone 12.09 webinar
7th World Congress of Nanoentomology
NDS NAB Transact testing
JC test 01
Pre-Release 3 Oct
DEX (Digital Employee Experience) conference 2024
test derek
TimeZone Test
TimeZone Test
Talent Events
Event Demo
Olympic Paris 2024 x
original event name for cloning testing
Olympic Paris 2024
Default payment method test
evexus Event - 509
Default payment method test2
Test Worker
Test Worker
charlie test
Arinex 1
NET24 Ho Chi Minh City Workshop 2024
Telefilm 2024 - International Exhibition of Film and Television Technology in Vietnam
Olympic Paris 2024
charlie test 2711
charlie test 2711 cloned
CICM SecurePay testing
The AI Submit 2024
Test webinar 04.12 - - - -
Taylor Swift Clone 04
Taylor Swift Clone 02
Taylor Swift
Taylor Swift Clone
Taylor Swift Clone 01
Import Test
The Trading Summit 2024 (HCM - Vietnam)
Electric Dreams: A Synthwave Extravaganza
Taylor Swift 16
Taylor Swift 12
Taylor Swift 14
Taylor Swift 15
Taylor Swift 17
Taylor Swift 20
Coin Based Hackathon 2024
Rose 01
Import Ticket
Vu Cat Tuong
STEM 1
Kids STEM
CLONE Innovate 2025: A Future Forward Summit
Innovate 2025: A Future Forward Summit
Petals & Sunshine Festival
webinar 05/02
Science
evexus Event - 273
evexus Event - 275
Association webinar 5.2
evexus Event - 274
Aurora Nights 2025 - Webinar
Seoul AI Seminar
Webinar Event - Lily AI - 20/02
evexus Event - 287
Taylor Swift 11
Swifties Only Social Contact
cloned event for Bree QA
evexus Event - 288
evexus Event - 289
Bree QA event
Tim's event
Ralph's event
Tim cloned enable all
Ralph clone event the last one
Hawaii AI Seminar
evexus Event - 293
Tokyo Seminar
Indiana AI Seminar
Registration ticket 2025
TechNova Summit
Event - 28 - 03 - 2025
TechNova Summit [2]
TechNova Summit [3]
Tech v1
Event 28/03/2025
Job Affairs
Fan Job
Webinar Event - Lily AI - 04/03
Event Registration
Association webinar 20.2
Fan's stock query
Registration
Aurora Nights 2025
Ralph test email
Taylor Swift 13
The Core 2025
Rose
The Thirdweb submit
Stress Test Conference 2026
Alan'event
World Congress of Medical Oncology
The AI Seoul Submit 2026
The Core 2026
Times are shown in your local time zone GMT
Comparison of Midline and Rutherford Morrison Incisions in Renal Transplantation: Early Postoperative Complications within 90 Days
Poster
Talk Description

Institution: Royal Prince Alfred Hospital - NSW, Australia

Abstract— The purpose of this paper is to compare the outcomes of midline and Rutherford-Morrison incisions in renal transplantation, focusing on wound complications, peri-graft haematoma, and biopsy-related complications within 90 days post-transplant. Background: Renal transplantation is the gold-standard treatment for end-stage kidney disease, yet little evidence exists on the impact of incision type, such as a lateral, Rutherford-Morrison incision compared to a lower midline incision on surgical outcomes, including wound complications. Incision type may also affect the position of the graft and may affect the ability to biopsy the graft and subsequent complications. The impact of incision type on wound complications and biopsy related complications remain unclear. Methods: A retrospective single-centre study was conducted of 413 renal transplant recipients at Royal Prince Alfred Hospital between January 2020 and January 2026. Patient demographics, donor characteristics, incision type, and post-transplant complications were recorded. Post operative surgical outcomes within 90 days, including wound complications, peri-graft haematoma and kidney transplant biopsy related complications were assessed. Results: Of 433 patients, 324 (74.83%) received a Rutherford-Morrison incision and 109 (25.17%) a midline incision. Biopsy-related complications occurred in 5.8% of Rutherford-Morrison and 8.1% of midline patients (p=0.652). Wound complications occurred 25.3% of Rutherford-Morrison and 18.3% of midline patients. Post-operative bleeding occurred in 9.9% of Rutherford-Morrison and 7.0% of midline patients. Mortality occurred in 0.6% of the Rutherford-Morrison and 2.8% of the midline patients. Conclusions: Midline incision is a safe and effective alternative to the Rutherford-Morrison incision in renal transplantation. It is associated with a lower incidence of wound complications and bleeding without increasing the risk of biopsy-related complications. Larger, multi-centre studies are warranted to confirm these findings and further guide surgical decision-making.
Speakers
Contributors
Authors

Dr Lam Susanna - , Dr Imogen Walsh - , Dr Ela Curic - , Dr Fiona Fraser - , Dr William Ziaziaris - , Dr Jerome Laurence - , Dr Carlo Pulitano -

Other Suggested ePosters
Privacy Statement Header

By confirming your acceptance below, you agree to our Privacy Policy